HomeCompareSSSGY vs MRK

SSSGY vs MRK: Dividend Comparison 2026

SSSGY yields 0.41% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SSSGY wins by $303.7K in total portfolio value· pulled ahead in Year 7
10 years
SSSGY
SSSGY
● Live price
0.41%
Share price
$42.02
Annual div
$0.17
5Y div CAGR
98.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$360.4K
Annual income
$240,813.88
Full SSSGY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SSSGY vs MRK

📍 SSSGY pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSSSGYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SSSGY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SSSGY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SSSGY
Annual income on $10K today (after 15% tax)
$34.91/yr
After 10yr DRIP, annual income (after tax)
$204,691.80/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SSSGY beats the other by $196,363.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SSSGY + MRK for your $10,000?

SSSGY: 50%MRK: 50%
100% MRK50/50100% SSSGY
Portfolio after 10yr
$208.6K
Annual income
$125,306.01/yr
Blended yield
60.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SSSGY
No analyst data
Altman Z
2.2
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SSSGY buys
0
MRK buys
0
No recent congressional trades found for SSSGY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSSSGYMRK
Forward yield0.41%2.76%
Annual dividend / share$0.17$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR98.8%32.7%
Portfolio after 10y$360.4K$56.8K
Annual income after 10y$240,813.88$9,798.13
Total dividends collected$330.2K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SSSGY vs MRK ($10,000, DRIP)

YearSSSGY PortfolioSSSGY Income/yrMRK PortfolioMRK Income/yrGap
1$10,782$81.65$11,206$366.19$424.00MRK
2$11,700$163.57$12,650$502.35$950.00MRK
3$12,849$329.78$14,407$694.19$1.6KMRK
4$14,421$672.87$16,585$967.82$2.2KMRK
5$16,834$1,403.14$19,342$1,363.89$2.5KMRK
6$21,055$3,043.10$22,913$1,947.19$1.9KMRK
7← crossover$29,601$7,071.77$27,662$2,823.89+$1.9KSSSGY
8$50,144$18,471.66$34,159$4,173.35+$16.0KSSSGY
9$111,792$58,137.87$43,337$6,308.80+$68.5KSSSGY
10$360,432$240,813.88$56,776$9,798.13+$303.7KSSSGY

SSSGY vs MRK: Complete Analysis 2026

SSSGYStock

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Full SSSGY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SSSGY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SSSGY vs SCHDSSSGY vs JEPISSSGY vs OSSSGY vs KOSSSGY vs MAINSSSGY vs JNJSSSGY vs ABBVSSSGY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.